Abera Bioscience AB (NGM:ABERA)

Abera Bioscience AB Statistics

Total Valuation

NGM:ABERA has a market cap or net worth of SEK 134.47 million. The enterprise value is 108.43 million.

Market Cap	134.47M
Enterprise Value	108.43M

Important Dates

The last earnings date was Tuesday, May 12, 2026.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

NGM:ABERA has 20.50 million shares outstanding.

Current Share Class	20.50M
Shares Outstanding	20.50M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.84%
Owned by Institutions (%)	n/a
Float	19.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.33
PB Ratio	5.73
P/TBV Ratio	5.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.67
EV / Sales	9.14
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.29

Financial Position

The company has a current ratio of 3.69

Current Ratio	3.69
Quick Ratio	3.63
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-8,205.50

Financial Efficiency

Return on equity (ROE) is -101.15% and return on invested capital (ROIC) is -63.80%.

Return on Equity (ROE)	-101.15%
Return on Assets (ROA)	-48.06%
Return on Invested Capital (ROIC)	-63.80%
Return on Capital Employed (ROCE)	-69.88%
Weighted Average Cost of Capital (WACC)	7.82%
Revenue Per Employee	2.37M
Profits Per Employee	-3.25M
Employee Count	5
Asset Turnover	0.56
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.82% in the last 52 weeks. The beta is 0.65, so NGM:ABERA's price volatility has been lower than the market average.

Beta (5Y)	0.65
52-Week Price Change	-22.82%
50-Day Moving Average	6.53
200-Day Moving Average	6.74
Relative Strength Index (RSI)	53.73
Average Volume (20 Days)	8,562

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NGM:ABERA had revenue of SEK 11.87 million and -16.26 million in losses.

Revenue	11.87M
Gross Profit	11.87M
Operating Income	-16.41M
Pretax Income	-16.26M
Net Income	-16.26M
EBITDA	-16.20M
EBIT	-16.41M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 26.04 million in cash and n/a in debt, with a net cash position of 26.04 million or 1.27 per share.

Cash & Cash Equivalents	26.04M
Total Debt	n/a
Net Cash	26.04M
Net Cash Per Share	1.27
Equity (Book Value)	23.49M
Book Value Per Share	n/a
Working Capital	20.36M

Cash Flow

In the last 12 months, operating cash flow was -10.11 million and capital expenditures -426,000, giving a free cash flow of -10.54 million.

Operating Cash Flow	-10.11M
Capital Expenditures	-426,000
Depreciation & Amortization	212,000
Net Borrowing	n/a
Free Cash Flow	-10.54M
FCF Per Share	-0.51

Margins

Gross margin is 100.00%, with operating and profit margins of -138.30% and -137.04%.

Gross Margin	100.00%
Operating Margin	-138.30%
Pretax Margin	-137.04%
Profit Margin	-137.04%
EBITDA Margin	-136.52%
EBIT Margin	-138.30%
FCF Margin	n/a

Dividends & Yields

NGM:ABERA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-12.09%
FCF Yield	-7.84%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2